RAC 0.63% $1.59 race oncology ltd

Industry news, page-586

  1. jd3
    235 Posts.
    lightbulb Created with Sketch. 164
    A) Having competition for your product
    B) Having the option to say no
    C) Having a board of directors with a large stake of company to ensure alignment of outcome with shareholders

    I think we're going to be okay on all three, with B & C currently ticked off, and the company working on generating the data to tick off A.

    A bit of patience.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.